ARTICLE | Distillery Therapeutics
A modified CRISPR adenine base editor with a minimal PAM requirement for DMD
July 2, 2021 9:40 PM UTC
DISEASE CATEGORY: Musculoskeletal
INDICATION: Muscular dystrophy...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Musculoskeletal
INDICATION: Muscular dystrophy...
BCIQ Company Profiles
BCIQ Target Profiles